TachoSil (Baxalta US Inc.)
Welcome to the PulseAid listing for the TachoSil drug offered from Baxalta US Inc.. This Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
| NON-PROPRIETARY NAME: | THROMBIN HUMAN and FIBRINOGEN |
| SUBSTANCE NAME: | HUMAN THROMBIN; FIBRINOGEN HUMAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | PATCH |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-04-05 |
| END MARKETING DATE: | 2020-05-31 |
TachoSil HUMAN PRESCRIPTION DRUG Details:
| Item Description | TachoSil from Baxalta US Inc. |
| LABELER NAME: | Baxalta US Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2; 5.5([USP’U]/1; mg/1) |
| START MARKETING DATE: | 2010-04-05 |
| END MARKETING DATE: | 2020-05-31 |
| PRODUCT ID: | 0944-8701_e7ac607f-3b8c-4e7f-aaec-e9421b020e62 |
| PRODUCT NDC: | 0944-8701 |
| APPLICATION NUMBER: | BLA125351 |
Other HUMAN THROMBIN; FIBRINOGEN HUMAN Pharmaceutical Manufacturers / Labelers:
